These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10809197)

  • 1. FDG PET detection of unknown primary tumors.
    Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
    J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
    Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
    Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
    Jeong HJ; Chung JK; Kim YK; Kim CY; Kim DG; Jeong JM; Lee DS; Jung HW; Lee MC
    J Nucl Med; 2002 Nov; 43(11):1432-7. PubMed ID: 12411544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ; Zhang YX; Wei H; Jia Q
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
    Rusthoven KE; Koshy M; Paulino AC
    Cancer; 2004 Dec; 101(11):2641-9. PubMed ID: 15517576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
    Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
    Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
    Yabuki K; Tsukuda M; Horiuchi C; Taguchi T; Nishimura G
    Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1785-92. PubMed ID: 20814690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
    Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
    Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of unknown occult primary tumors using positron emission tomography.
    Kole AC; Nieweg OE; Pruim J; Hoekstra HJ; Koops HS; Roodenburg JL; Vaalburg W; Vermey A
    Cancer; 1998 Mar; 82(6):1160-6. PubMed ID: 9506364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search of an unknown primary tumour presenting with extracervical metastases: the diagnostic performance of FDG-PET.
    Joshi U; van der Hoeven JJ; Comans EF; Herder GJ; Teule GJ; Hoekstra OS
    Br J Radiol; 2004 Dec; 77(924):1000-6. PubMed ID: 15569641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
    Sève P; Billotey C; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2007 Jan; 109(2):292-9. PubMed ID: 17167760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.